Generalize
Information
We believe in the importance of owning your own genome, the unique DNA blueprint that defines who you are. That's why we created GenomesDAO, a secure and private DNA data bank that empowers you to take control of your genome. Through the use of AMD SVS-ES Vault and blockchain technology, we address concerns regarding privacy, security, and ownership in DNA testing and sharing. Our goal is to build the world's largest user-owned genomic data bank, ensuring the future of personalized medicine.
$GENE is a deflationary utility token utilized by pharmaceutical companies and research organizations to offer users incentives for accessing their data. Genomes.io facilitates these data queries, and individuals have the choice to approve or deny them. $GENE is an ERC-20 token built on the Ethereum blockchain.
Data buyers, such as pharmaceutical companies and research organizations, will have the ability to set the price they offer individuals for each query. This price will be translated into $GENE tokens for cost-effectiveness, which is why the tokens hold value.
Information
Answers
Coin ranking
Popular Q&A
- Can you provide a detailed comparison between $genslr coin and other cryptocurrencies? I would like to know how $genslr coin stands out in terms of technology, market performance, and potential use cases.2021-11-24
- I'm interested in buying $genslr coin, but I'm not sure how to go about it. Can you provide me with some guidance on how to purchase $genslr coin and recommend the best platform to do so?2021-11-24
- What are the potential future trends and prospects for the $genslr coin?2021-11-24
- What are the advantages and benefits of investing in $genslr coin? How can investing in $genslr coin potentially yield profits and help investors achieve their financial goals?2021-11-24
- As an expert in SEO and familiar with the latest ranking algorithms of Google, I would like to know what potential risks are associated with trading $genslr coin in the cryptocurrency market? Can you provide a detailed analysis of the risks involved?2021-11-24